S1PR1 and synovial sarcoma: In addition, sphingosine 1-phosphate (S1P) significantly promotes the production of IFN-γ by CD4 T cells in primary SS patients compared to healthy controls, and modulating the S1P1 signaling pathway may be a novel strategy for the treatment of primary SS [130].